HIGHLIGHTS
- What: The authors intended to compare the predictive potency of the candidate markers on the whole HNSCC sample and in different TNM8 localizations (including p16 positive HNSCC patients as a new subgroup).
- Who: HEAD and colleagues from the Department of Oto-Rhino-Laryngology and Head-Neck Surgery, Semmelweis University, Budapest, Hungary have published the research: survival (OS), cancer specific survival (CSS) and fitness to treatment. Optimal evaluation of nutritional status requires a marker which is sensitive and affordable enough for regular use. As laboratory tests became an integral part of patient workup, more prognostic and . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.